|Bid||0.9850 x 0|
|Ask||1.0100 x 0|
|Day's Range||1.0100 - 1.0100|
|52 Week Range||0.7150 - 2.4400|
|Beta (5Y Monthly)||1.59|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov. 10, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.00|
The heavy selling pressure might have exhausted for Ampio (AMPE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
A positive second-quarter earnings report and anticipation of further details to be discussed this afternoon helped this beaten-down biotech stock recover some previous losses.
NEW YORK, NY / ACCESSWIRE / May 5, 2021 / Ampio Pharmaceuticals, Inc. (NYSE:AMPE) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 5, 2021 at 4:30 PM Eastern Time.